Oxidative stress is a condition in which oxidant metabolites exert tox
ic effects because of their increased production or an altered cellula
r mechanism of protection. The heart needs oxygen but it is also susce
ptible to oxidative stress, which occurs during post-ischaemic reperfu
sion, for example. Ischaemia causes alterations in the defence mechani
sms against oxygen free radicals. At the same time, production of oxyg
en free radicals increases. In man, there is evidence of oxidative str
ess during surgical reperfusion of the whole heart? or after thromboly
sis, and it is related to transient left ventricular dysfunction or st
unning. At present, there are few data on oxidative stress in the fail
ing heart. It is not clear whether the defence mechanisms of the myocy
te are altered or whether the production of oxygen free radicals is in
creased, or both. Recent data have shown a close link between oxidativ
e stress and apoptosis. Importantly, tumour necrosis factor causes a r
apid rise in intracellular reactive oxygen intermediates and apoptosis
. This series of events is not confined to the myocytes, but also occu
rs at the level of endothelium, where tumour necrosis factor causes ex
pression of inducible nitric oxide synthase, production of the reactiv
e radical nitric oxide, oxidative stress and apoptosis. The immunologi
cal response to heart failure may result in endothelial and myocyte dy
sfunction through oxidative stress-mediated apoptosis. A better unders
tanding of these mechanisms may lead to novel therapeutic strategies.